WDNA vs. ARKG
WDNA (WisdomTree BioRevolution Fund) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. WDNA is passively managed, while ARKG is actively managed. Over the past 5 years, WDNA returned -4.78%/yr vs -14.59%/yr for ARKG. Their correlation of 0.89 suggests significant overlap in exposure. WDNA charges 0.45%/yr vs 0.75%/yr for ARKG.
Performance
WDNA vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 8.96% return, which is significantly lower than ARKG's 25.20% return.
WDNA
- 1D
- 2.94%
- 1M
- 2.56%
- YTD
- 8.96%
- 6M
- 10.44%
- 1Y
- 50.50%
- 3Y*
- 3.54%
- 5Y*
- -4.78%
- 10Y*
- —
ARKG
- 1D
- 6.93%
- 1M
- 21.79%
- YTD
- 25.20%
- 6M
- 13.70%
- 1Y
- 60.42%
- 3Y*
- 2.68%
- 5Y*
- -14.59%
- 10Y*
- 7.74%
WDNA vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 8.96% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 25.20% | 23.04% | -28.24% | 16.22% | -53.90% | -22.17% |
Correlation
The correlation between WDNA and ARKG is 0.83, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.83 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.88 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.89 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2021 | 0.89 |
The correlation between WDNA and ARKG has been stable across timeframes, ranging from 0.83 to 0.89 - a consistent structural relationship.
WDNA vs. ARKG - Sectors Allocation Comparison
Sectors
WDNA
ARKG
Healthcare
Basic Materials
-
Consumer Defensive
-
Energy
-
Communication Services
-
-
Consumer Cyclical
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
WDNA
ARKG
Basic Materials
WDNA
ARKG
-
Consumer Defensive
WDNA
ARKG
-
Energy
WDNA
ARKG
-
Communication Services
WDNA
-
ARKG
-
Consumer Cyclical
WDNA
-
ARKG
-
Financial Services
WDNA
-
ARKG
Industrials
WDNA
-
ARKG
-
Real Estate
WDNA
-
ARKG
-
Technology
WDNA
-
ARKG
-
Utilities
WDNA
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. ARKG — Risk / Return Rank
WDNA
ARKG
WDNA vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WDNA | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.52 | ||
| Sortino ratioReturn per unit of downside risk | +0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.24 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 4.34 | 2.21 | +2.13 |
| Martin ratioReturn relative to average drawdown | 9.85 | 5.29 | +4.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WDNA | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.98 | 1.46 | +0.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | -0.32 | +0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.19 | 0.15 | -0.34 |
Drawdowns
WDNA vs. ARKG - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for WDNA and ARKG.
Loading charts...
Drawdown Indicators
| WDNA | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -83.59% | +24.72% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -27.51% | +15.81% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -51.96% | +13.71% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -80.18% | +21.31% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -29.86% | -67.55% | +37.69% |
Average DrawdownAverage peak-to-trough decline | -35.64% | -35.88% | +0.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 11.46% | -6.32% |
Volatility
WDNA vs. ARKG - Volatility Comparison
The current volatility for WisdomTree BioRevolution Fund (WDNA) is 7.35%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.94%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.35% | 12.94% | -5.59% |
Volatility (6M)Calculated over the trailing 6-month period | 16.59% | 29.51% | -12.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.66% | 41.62% | -15.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.08% | 45.71% | -20.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 41.17% | -16.10% |
WDNA vs. ARKG - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
WDNA vs. ARKG - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.19%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
WDNA WisdomTree BioRevolution Fund | 4.19% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and ARKG have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (12.94%) compared to WDNA (7.35%). In terms of maximum drawdown, WDNA dropped -58.87% vs ARKG's -83.59%.
On 5-year performance, WDNA leads with -4.78% vs -14.59% for ARKG. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 7.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, WDNA has performed better with a -4.78% return vs -14.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
WDNA is cheaper with a 0.45% expense ratio, compared with 0.75% for ARKG.
WDNA has the higher dividend yield at 4.19%, compared with 0.00% for ARKG.
They also come from different issuers: WisdomTree and ARK. Their fees differ too: 0.45% for WDNA and 0.75% for ARKG.
WDNA currently has the higher Sharpe Ratio (1.98 vs 1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer